Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | MMP14 | P50281 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL516622 | 0.96 | TSHR (0.66) | TSHRHPGDHCAR2CYP3A4TDP1 | |
| SCHEMBL5464973 | 0.88 | TSHR (0.59) | TSHRHPGDHCAR2CYP3A4ATM | |
| Acrylic Acid SCHEMBL3844152 | 0.84 | TSHR (0.81) | TSHRHPGDHCAR2CYP3A4TDP1 | |
| Acrylic Acid SCHEMBL7263337 | 0.84 | TSHR (0.81) | TSHRHPGDHCAR2CYP3A4TDP1 | |
| SCHEMBL497406 | 0.84 | TSHR (0.48) | TSHRHPGDCYP3A4TDP1ATM | |
| SCHEMBL4125846 | 0.84 | TSHR (0.58) | TSHRHPGDHCAR2CYP3A4TDP1 | |
| Acrylic Acid SCHEMBL16151343 | 0.84 | TSHR (0.67) | TSHRHPGDHCAR2CYP3A4TDP1 | |
| SCHEMBL338002 | 0.83 | TSHR (0.88) | TSHRHPGDHCAR2CYP3A4TDP1 | |
| SCHEMBL6133965 | 0.82 | TSHR (0.72) | TSHRHPGDHCAR2CYP3A4TDP1 | |
| Acrylic Acid Methyl Ester SCHEMBL5718144 | 0.80 | TSHR (0.72) | TSHRHPGDHCAR2CYP3A4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120088053-A1 | Release Sheet and Pressure-Sensitive Adhesive Article | LINTEC CORPORATION | 2012-04-12 | — | — | US | disclosed |
| US-20100215881-A1 | DOUBLE-FACED PRESSURE-SENSITIVE ADHESIVE SHEET USED FOR ELECTRONIC COMPONENTS AND PRODUCING METHOD THEREOF | LINTEC CORPORATION (JP) | 2010-08-26 | — | — | US | disclosed |
| US-20100021669-A1 | RELEASE SHEET AND PRESSURE-SENSITIVE ADHESIVE ARTICLE | LINTEC CORPORATION (JP) | 2010-01-28 | — | — | US | disclosed |
| US-20050226919-A1 | Device for transdermal administration for the treatment of urinary tract disorders | UCB PHARMA GMBH (DE) | 2005-10-13 | — | — | US | disclosed |
| EP-1293198-B1 | Device for transdermal administration for the treatment of urinary tract disorders | SANOL ARZNEI SCHWARZ GMBH (DE) | 2005-02-09 | — | — | EP | disclosed |
| WO-2003024432-A2 | DEVICE FOR TRANSDERMAL ADMINISTRATION FOR THE TREATMENT OF URINARY TRACT DISORDERS | SCHWARZ PHARMA AG (DE) | 2003-03-27 | — | — | WO | disclosed |
| EP-1293198-A1 | Device for transdermal administration for the treatment of urinary tract disorders | SCHWARZ PHARMA AG (DE) | 2003-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050226919-A1 | Device for transdermal administration for the treatment of urinary tract disorders | AR, CYP17A1, TACR1 | TSHR 465/4885HPGD 287/4885HCAR2 504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.